National Cancer Institute; Notice of Closed Meetings, 34683-34684 [2017-15615]
Download as PDF
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
30-Day notice of submission of
information collection approval from
the Office of Management and Budget
and request for comments.
ACTION:
As part of a Federal
Government-wide effort to streamline
the process to seek feedback from the
public on service delivery, U.S.
Department of Health and Human
Services has submitted a Generic
Information Collection Request (Generic
ICR): ‘‘Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery’’ to OMB for
approval under the Paperwork
Reduction Act (PRA).
DATES: Comments on the ICR must be
received on or before August 25, 2017.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Report Clearance
Officer, at either Sherrette.Funn@
HHS.GOV or (202) 795–7714.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery.
Abstract: The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:49 Jul 25, 2017
Jkt 241001
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
The Agency received no comments in
response to the 60-day notice published
in the May 8, 2017, issue of the Federal
Register (82 FR 21392–21393).
Current Actions: Extension of
approval for a collection of information.
Type of Review: Extension.
Affected Public: Individuals,
households, professionals, public/
private sector.
Average Expected Annual Number of
Activities: 40.
Respondents per Activity: 25,000.
Annual Responses: 1,000,000.
Frequency of Response: Once per
request.
Average minutes per response: 5.
Burden hours: 500,000 hours
annually.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
Darius Taylor,
Deputy Information Collection Officer.
[FR Doc. 2017–15318 Filed 7–25–17; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, August
01, 2017, 12:00 p.m. to August 02, 2017,
05:00 p.m., National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD,
20892 which was published in the
Federal Register on July 12, 2017, 82 FR
32189.
The meeting will be held on August
1, 2017 and will start at 2:00 p.m. and
end at 5:00 p.m. The meeting location
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
34683
remains the same. The meeting is closed
to the public.
Dated: July 20, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15614 Filed 7–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI SPORE
Review.
Date: October 19–20, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W120, Bethesda, MD
20892–9750, 240–276–6457 mh101v@nih.gov
Name of Committee: National Cancer
Institute Special Emphasis Panel NCI
Program Project IV (P01) Review.
Date: October 26–27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Klaus B Piontek, MD,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W116,
Bethesda, MD 20892–9750, 240–276–5413
klaus.piontek@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
E:\FR\FM\26JYN1.SGM
26JYN1
34684
Federal Register / Vol. 82, No. 142 / Wednesday, July 26, 2017 / Notices
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15615 Filed 7–25–17; 8:45 am]
BILLING CODE 4140–01–P
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Anne E Schaffner, Ph.D.,
Chief, Scientific Review Branch, Division Of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: July 20, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2017–15616 Filed 7–25–17; 8:45 am]
National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Clinical and
Epidemiological Grant Applications.
Date: August 11, 2017.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
CBPL No.
...........
...........
...........
...........
...........
D4006
D95
D473
D445
D4294
D5002
D4052
D1796
D4007
U.S. Customs and Border Protection
Accreditation and Approval of Intertek
USA, Inc., as a Commercial Gauger
and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that
Intertek USA, Inc., has been approved to
gauge petroleum and certain petroleum
products and accredited to test
petroleum and certain petroleum
products for customs purposes for the
next three years as of May 5, 2016.
DATES: Intertek USA, Inc., was
accredited and approved as a
SUMMARY:
17:49 Jul 25, 2017
API chapters
Title
3 .....................
7 .....................
8 .....................
11 ...................
12 ...................
17 ...................
Tank gauging.
Temperature determination.
Sampling.
Physical Properties Data.
Calculations.
Maritime measurement.
Intertek USA, Inc., is accredited for
the following laboratory analysis
procedures and methods for petroleum
and certain petroleum products set forth
by the U.S. Customs and Border
Protection Laboratory Methods (CBPL)
and American Society for Testing and
Materials (ASTM):
Title
Standard Test Method for Water in Crude Oil by Distillation.
Standard Test Method for Water in Petroleum Products and Bituminous Materials by Distillation.
Standard Test Method for Sediment in Crude Oils and Fuel Oils by the Extraction Method.
Standard Test Method for Kinematic Viscosity of Transparent and Opaque Liquids.
Standard Test Method for Sulfur in Petroleum and Petroleum Products by Energy-Dispersive X-ray Fluorescence Spectrometry.
Standard Test Method for Density and Relative Density of Crude Oils by Digital Density Analyzer.
Standard Test Method for Density and Relative Density of Liquids by Digital Density Meter.
Standard Test Method for Water and Sediment in Fuel Oils by the Centrifuge Method.
Standard Test Method for Water and Sediment in Crude Oil by the Centrifuge Method.
Anyone wishing to employ this entity
to conduct laboratory analyses and
gauger services should request and
receive written assurances from the
entity that it is accredited or approved
by the U.S. Customs and Border
Protection to conduct the specific test or
gauger service requested. Alternatively,
inquiries regarding the specific test or
gauger service this entity is accredited
VerDate Sep<11>2014
DEPARTMENT OF HOMELAND
SECURITY
ASTM
27–46 ...........
27–48 ...........
27–54 ...........
Pending ........
mstockstill on DSK30JT082PROD with NOTICES
27–03
27–04
27–06
27–11
27–13
BILLING CODE 4140–01–P
commercial gauger and laboratory as of
May 5, 2016. The next triennial
inspection date will be scheduled for
May 2019.
FOR FURTHER INFORMATION CONTACT:
Christopher J. Mocella, Laboratories and
Scientific Services Directorate, U.S.
Customs and Border Protection, 1300
Pennsylvania Avenue NW., Suite
1500N, Washington, DC 20229, tel. 202–
344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Intertek USA,
Inc., 16025 Jacintoport Blvd., Suite B,
Houston, TX 77015, has been approved
to gauge petroleum and certain
petroleum products and accredited to
test petroleum and certain petroleum
products for customs purposes, in
accordance with the provisions of 19
CFR 151.12 and 19 CFR 151.13. Intertek
USA, Inc., is approved for the following
gauging procedures for petroleum and
certain petroleum products from the
American Petroleum Institute (API):
Jkt 241001
or approved to perform may be directed
to the U.S. Customs and Border
Protection by calling (202) 344–1060.
The inquiry may also be sent to
CBPGaugersLabs@cbp.dhs.gov. Please
reference the Web site listed below for
a complete listing of CBP approved
gaugers and accredited laboratories.
https://www.cbp.gov/about/labs-
PO 00000
Frm 00062
Fmt 4703
Sfmt 9990
scientific/commercial-gaugers-andlaboratories.
Dated: July 18, 2017.
Ira S. Reese,
Executive Director, Laboratories and
Scientific Services Directorate.
[FR Doc. 2017–15639 Filed 7–25–17; 8:45 am]
BILLING CODE 9111–14–P
E:\FR\FM\26JYN1.SGM
26JYN1
Agencies
[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Pages 34683-34684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15615]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel NCI SPORE Review.
Date: October 19-20, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Rockville, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W120, Bethesda, MD 20892-9750, 240-276-6457 mh101v@nih.gov
Name of Committee: National Cancer Institute Special Emphasis
Panel NCI Program Project IV (P01) Review.
Date: October 26-27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Klaus B Piontek, MD, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W116, Bethesda, MD 20892-9750, 240-276-5413 klaus.piontek@nih.gov
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
[[Page 34684]]
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-15615 Filed 7-25-17; 8:45 am]
BILLING CODE 4140-01-P